ERBB2 and cancer: The worst prognoses and highest metastatic capacity are observed in HER2-positive and TNBC subtypes, typically found in stages 3 or 4 of the disease, where cancer cells have spread to axillary lymph nodes or other organs, and tumors are 5 cm or larger [2,25,37].